nodes	percent_of_prediction	percent_of_DWPC	metapath
Dorzolamide—CA6—ear—melanoma	0.0245	0.287	CbGeAlD
Dorzolamide—CA6—hair follicle—melanoma	0.0129	0.151	CbGeAlD
Dorzolamide—CA2—hair follicle—melanoma	0.00444	0.0522	CbGeAlD
Dorzolamide—Throat sore—Docetaxel—melanoma	0.00444	0.00641	CcSEcCtD
Dorzolamide—Oropharyngeal discomfort—Docetaxel—melanoma	0.0044	0.00636	CcSEcCtD
Dorzolamide—CA12—eye—melanoma	0.00431	0.0507	CbGeAlD
Dorzolamide—Cerebrovascular accident—Bleomycin—melanoma	0.00422	0.0061	CcSEcCtD
Dorzolamide—Scotoma—Docetaxel—melanoma	0.00421	0.00609	CcSEcCtD
Dorzolamide—Rash erythematous—Docetaxel—melanoma	0.00418	0.00604	CcSEcCtD
Dorzolamide—Alopecia—Vemurafenib—melanoma	0.00418	0.00603	CcSEcCtD
Dorzolamide—Erythema—Vemurafenib—melanoma	0.00411	0.00594	CcSEcCtD
Dorzolamide—Dysgeusia—Vemurafenib—melanoma	0.00403	0.00582	CcSEcCtD
Dorzolamide—Eye pain—Carmustine—melanoma	0.004	0.00578	CcSEcCtD
Dorzolamide—Back pain—Vemurafenib—melanoma	0.00398	0.00575	CcSEcCtD
Dorzolamide—Eye pain—Temozolomide—melanoma	0.00387	0.00559	CcSEcCtD
Dorzolamide—Amnesia—Carmustine—melanoma	0.00385	0.00556	CcSEcCtD
Dorzolamide—Nasal congestion—Temozolomide—melanoma	0.00383	0.00554	CcSEcCtD
Dorzolamide—Eye irritation—Docetaxel—melanoma	0.00375	0.00541	CcSEcCtD
Dorzolamide—Amnesia—Temozolomide—melanoma	0.00372	0.00537	CcSEcCtD
Dorzolamide—Dermatitis exfoliative—Temozolomide—melanoma	0.0037	0.00535	CcSEcCtD
Dorzolamide—CA6—head—melanoma	0.00365	0.0429	CbGeAlD
Dorzolamide—Diplopia—Carmustine—melanoma	0.00361	0.00522	CcSEcCtD
Dorzolamide—CA4—neck—melanoma	0.00359	0.0422	CbGeAlD
Dorzolamide—Cough—Vemurafenib—melanoma	0.00359	0.00519	CcSEcCtD
Dorzolamide—Bronchospasm—Bleomycin—melanoma	0.00352	0.00508	CcSEcCtD
Dorzolamide—Oropharyngeal pain—Docetaxel—melanoma	0.00352	0.00508	CcSEcCtD
Dorzolamide—Arthralgia—Vemurafenib—melanoma	0.0035	0.00506	CcSEcCtD
Dorzolamide—Diplopia—Temozolomide—melanoma	0.00349	0.00505	CcSEcCtD
Dorzolamide—Toxic epidermal necrolysis—Dactinomycin—melanoma	0.00348	0.00502	CcSEcCtD
Dorzolamide—Lacrimation increased—Docetaxel—melanoma	0.00347	0.00502	CcSEcCtD
Dorzolamide—Affect lability—Temozolomide—melanoma	0.00344	0.00497	CcSEcCtD
Dorzolamide—CA1—eye—melanoma	0.00342	0.0402	CbGeAlD
Dorzolamide—Anaphylactic shock—Vemurafenib—melanoma	0.00336	0.00485	CcSEcCtD
Dorzolamide—Mood swings—Temozolomide—melanoma	0.00331	0.00478	CcSEcCtD
Dorzolamide—Respiratory failure—Docetaxel—melanoma	0.00326	0.00471	CcSEcCtD
Dorzolamide—Weight decreased—Bleomycin—melanoma	0.00324	0.00468	CcSEcCtD
Dorzolamide—Acute coronary syndrome—Bleomycin—melanoma	0.00314	0.00454	CcSEcCtD
Dorzolamide—Toxic epidermal necrolysis—Temozolomide—melanoma	0.00314	0.00454	CcSEcCtD
Dorzolamide—Hypotension—Vemurafenib—melanoma	0.00314	0.00453	CcSEcCtD
Dorzolamide—Myocardial infarction—Bleomycin—melanoma	0.00313	0.00452	CcSEcCtD
Dorzolamide—CA5B—mammalian vulva—melanoma	0.00307	0.0361	CbGeAlD
Dorzolamide—Musculoskeletal discomfort—Vemurafenib—melanoma	0.00306	0.00442	CcSEcCtD
Dorzolamide—CA2—neck—melanoma	0.00298	0.035	CbGeAlD
Dorzolamide—Stevens-Johnson syndrome—Dactinomycin—melanoma	0.00295	0.00426	CcSEcCtD
Dorzolamide—Decreased appetite—Vemurafenib—melanoma	0.00292	0.00422	CcSEcCtD
Dorzolamide—Bronchitis—Temozolomide—melanoma	0.0029	0.00419	CcSEcCtD
Dorzolamide—Fatigue—Vemurafenib—melanoma	0.00289	0.00418	CcSEcCtD
Dorzolamide—Pulmonary oedema—Docetaxel—melanoma	0.00285	0.00411	CcSEcCtD
Dorzolamide—Dysuria—Temozolomide—melanoma	0.00282	0.00408	CcSEcCtD
Dorzolamide—Hyperglycaemia—Carmustine—melanoma	0.00282	0.00407	CcSEcCtD
Dorzolamide—Upper respiratory tract infection—Temozolomide—melanoma	0.0028	0.00405	CcSEcCtD
Dorzolamide—Erectile dysfunction—Temozolomide—melanoma	0.00278	0.00402	CcSEcCtD
Dorzolamide—Depression—Carmustine—melanoma	0.00278	0.00401	CcSEcCtD
Dorzolamide—Agranulocytosis—Dactinomycin—melanoma	0.00278	0.00401	CcSEcCtD
Dorzolamide—Weight decreased—Temozolomide—melanoma	0.00273	0.00395	CcSEcCtD
Dorzolamide—Hyperglycaemia—Temozolomide—melanoma	0.00272	0.00393	CcSEcCtD
Dorzolamide—Urinary tract infection—Carmustine—melanoma	0.00271	0.00391	CcSEcCtD
Dorzolamide—Depression—Temozolomide—melanoma	0.00268	0.00388	CcSEcCtD
Dorzolamide—Stevens-Johnson syndrome—Temozolomide—melanoma	0.00267	0.00385	CcSEcCtD
Dorzolamide—Body temperature increased—Vemurafenib—melanoma	0.00265	0.00384	CcSEcCtD
Dorzolamide—Pharyngitis—Dactinomycin—melanoma	0.00265	0.00383	CcSEcCtD
Dorzolamide—Urinary tract infection—Temozolomide—melanoma	0.00262	0.00378	CcSEcCtD
Dorzolamide—Cardiac failure congestive—Docetaxel—melanoma	0.00256	0.0037	CcSEcCtD
Dorzolamide—Alopecia—Bleomycin—melanoma	0.00253	0.00366	CcSEcCtD
Dorzolamide—Erythema multiforme—Dactinomycin—melanoma	0.00252	0.00365	CcSEcCtD
Dorzolamide—Sinusitis—Temozolomide—melanoma	0.00252	0.00365	CcSEcCtD
Dorzolamide—Erythema—Bleomycin—melanoma	0.00249	0.0036	CcSEcCtD
Dorzolamide—Hallucination—Carmustine—melanoma	0.00249	0.00359	CcSEcCtD
Dorzolamide—Hypersensitivity—Vemurafenib—melanoma	0.00247	0.00357	CcSEcCtD
Dorzolamide—Visual disturbance—Docetaxel—melanoma	0.00245	0.00354	CcSEcCtD
Dorzolamide—CA12—head—melanoma	0.00245	0.0288	CbGeAlD
Dorzolamide—Asthenia—Vemurafenib—melanoma	0.00241	0.00348	CcSEcCtD
Dorzolamide—Visual impairment—Carmustine—melanoma	0.00241	0.00348	CcSEcCtD
Dorzolamide—Hallucination—Temozolomide—melanoma	0.0024	0.00347	CcSEcCtD
Dorzolamide—Pharyngitis—Temozolomide—melanoma	0.0024	0.00346	CcSEcCtD
Dorzolamide—Cardiac failure—Docetaxel—melanoma	0.00238	0.00344	CcSEcCtD
Dorzolamide—Pruritus—Vemurafenib—melanoma	0.00238	0.00343	CcSEcCtD
Dorzolamide—Alopecia—Dactinomycin—melanoma	0.00236	0.00341	CcSEcCtD
Dorzolamide—Visual impairment—Temozolomide—melanoma	0.00233	0.00336	CcSEcCtD
Dorzolamide—Erythema—Dactinomycin—melanoma	0.00232	0.00336	CcSEcCtD
Dorzolamide—Pain in extremity—Docetaxel—melanoma	0.00232	0.00336	CcSEcCtD
Dorzolamide—Diarrhoea—Vemurafenib—melanoma	0.0023	0.00332	CcSEcCtD
Dorzolamide—Erythema multiforme—Temozolomide—melanoma	0.00228	0.0033	CcSEcCtD
Dorzolamide—Tinnitus—Temozolomide—melanoma	0.00225	0.00325	CcSEcCtD
Dorzolamide—Arrhythmia—Carmustine—melanoma	0.00223	0.00323	CcSEcCtD
Dorzolamide—Dizziness—Vemurafenib—melanoma	0.00222	0.00321	CcSEcCtD
Dorzolamide—CA2—eye—melanoma	0.00222	0.026	CbGeAlD
Dorzolamide—Alopecia—Carmustine—melanoma	0.00221	0.00319	CcSEcCtD
Dorzolamide—CA5B—head—melanoma	0.0022	0.0258	CbGeAlD
Dorzolamide—CA2—retina—melanoma	0.0022	0.0258	CbGeAlD
Dorzolamide—Erythema—Carmustine—melanoma	0.00218	0.00314	CcSEcCtD
Dorzolamide—Cough—Bleomycin—melanoma	0.00217	0.00314	CcSEcCtD
Dorzolamide—Vomiting—Vemurafenib—melanoma	0.00213	0.00308	CcSEcCtD
Dorzolamide—Alopecia—Temozolomide—melanoma	0.00213	0.00308	CcSEcCtD
Dorzolamide—Chest pain—Bleomycin—melanoma	0.00212	0.00307	CcSEcCtD
Dorzolamide—Rash—Vemurafenib—melanoma	0.00212	0.00306	CcSEcCtD
Dorzolamide—Dermatitis—Vemurafenib—melanoma	0.00211	0.00306	CcSEcCtD
Dorzolamide—Back pain—Carmustine—melanoma	0.0021	0.00304	CcSEcCtD
Dorzolamide—Headache—Vemurafenib—melanoma	0.0021	0.00304	CcSEcCtD
Dorzolamide—Erythema—Temozolomide—melanoma	0.0021	0.00304	CcSEcCtD
Dorzolamide—Discomfort—Bleomycin—melanoma	0.0021	0.00303	CcSEcCtD
Dorzolamide—Toxic epidermal necrolysis—Docetaxel—melanoma	0.00209	0.00302	CcSEcCtD
Dorzolamide—Dysgeusia—Temozolomide—melanoma	0.00206	0.00298	CcSEcCtD
Dorzolamide—Confusional state—Bleomycin—melanoma	0.00205	0.00296	CcSEcCtD
Dorzolamide—Vision blurred—Carmustine—melanoma	0.00205	0.00296	CcSEcCtD
Dorzolamide—Oedema—Bleomycin—melanoma	0.00203	0.00294	CcSEcCtD
Dorzolamide—Anaphylactic shock—Bleomycin—melanoma	0.00203	0.00294	CcSEcCtD
Dorzolamide—Back pain—Temozolomide—melanoma	0.00203	0.00294	CcSEcCtD
Dorzolamide—Nausea—Vemurafenib—melanoma	0.00199	0.00288	CcSEcCtD
Dorzolamide—Vision blurred—Temozolomide—melanoma	0.00198	0.00286	CcSEcCtD
Dorzolamide—Bronchospasm—Docetaxel—melanoma	0.00197	0.00285	CcSEcCtD
Dorzolamide—Discomfort—Dactinomycin—melanoma	0.00196	0.00283	CcSEcCtD
Dorzolamide—Angina pectoris—Docetaxel—melanoma	0.00195	0.00282	CcSEcCtD
Dorzolamide—CA1—head—melanoma	0.00194	0.0228	CbGeAlD
Dorzolamide—Anorexia—Bleomycin—melanoma	0.00194	0.0028	CcSEcCtD
Dorzolamide—CA2—skin of body—melanoma	0.00193	0.0226	CbGeAlD
Dorzolamide—Angioedema—Temozolomide—melanoma	0.00192	0.00278	CcSEcCtD
Dorzolamide—Hypotension—Bleomycin—melanoma	0.0019	0.00275	CcSEcCtD
Dorzolamide—Oedema—Dactinomycin—melanoma	0.0019	0.00274	CcSEcCtD
Dorzolamide—Vertigo—Temozolomide—melanoma	0.00189	0.00273	CcSEcCtD
Dorzolamide—Hypertension—Carmustine—melanoma	0.00188	0.00271	CcSEcCtD
Dorzolamide—Palpitations—Temozolomide—melanoma	0.00186	0.00268	CcSEcCtD
Dorzolamide—Musculoskeletal discomfort—Bleomycin—melanoma	0.00185	0.00268	CcSEcCtD
Dorzolamide—Chest pain—Carmustine—melanoma	0.00185	0.00268	CcSEcCtD
Dorzolamide—Anxiety—Carmustine—melanoma	0.00185	0.00267	CcSEcCtD
Dorzolamide—Cough—Temozolomide—melanoma	0.00183	0.00265	CcSEcCtD
Dorzolamide—Paraesthesia—Bleomycin—melanoma	0.00183	0.00264	CcSEcCtD
Dorzolamide—Weight decreased—Docetaxel—melanoma	0.00182	0.00262	CcSEcCtD
Dorzolamide—Hypertension—Temozolomide—melanoma	0.00182	0.00262	CcSEcCtD
Dorzolamide—Dyspnoea—Bleomycin—melanoma	0.00181	0.00262	CcSEcCtD
Dorzolamide—Anorexia—Dactinomycin—melanoma	0.00181	0.00261	CcSEcCtD
Dorzolamide—Confusional state—Carmustine—melanoma	0.00179	0.00259	CcSEcCtD
Dorzolamide—Arthralgia—Temozolomide—melanoma	0.00179	0.00259	CcSEcCtD
Dorzolamide—Anxiety—Temozolomide—melanoma	0.00178	0.00258	CcSEcCtD
Dorzolamide—Oedema—Carmustine—melanoma	0.00178	0.00257	CcSEcCtD
Dorzolamide—Stevens-Johnson syndrome—Docetaxel—melanoma	0.00177	0.00256	CcSEcCtD
Dorzolamide—Discomfort—Temozolomide—melanoma	0.00177	0.00256	CcSEcCtD
Dorzolamide—Decreased appetite—Bleomycin—melanoma	0.00177	0.00256	CcSEcCtD
Dorzolamide—Acute coronary syndrome—Docetaxel—melanoma	0.00176	0.00255	CcSEcCtD
Dorzolamide—CA2—mammalian vulva—melanoma	0.00176	0.0207	CbGeAlD
Dorzolamide—Myocardial infarction—Docetaxel—melanoma	0.00175	0.00253	CcSEcCtD
Dorzolamide—Dry mouth—Temozolomide—melanoma	0.00175	0.00253	CcSEcCtD
Dorzolamide—Pain—Bleomycin—melanoma	0.00174	0.00251	CcSEcCtD
Dorzolamide—Conjunctivitis—Docetaxel—melanoma	0.00174	0.00251	CcSEcCtD
Dorzolamide—Confusional state—Temozolomide—melanoma	0.00173	0.0025	CcSEcCtD
Dorzolamide—Musculoskeletal discomfort—Dactinomycin—melanoma	0.00173	0.0025	CcSEcCtD
Dorzolamide—Oedema—Temozolomide—melanoma	0.00172	0.00248	CcSEcCtD
Dorzolamide—Anaphylactic shock—Temozolomide—melanoma	0.00172	0.00248	CcSEcCtD
Dorzolamide—Anorexia—Carmustine—melanoma	0.00169	0.00245	CcSEcCtD
Dorzolamide—Epistaxis—Docetaxel—melanoma	0.00169	0.00244	CcSEcCtD
Dorzolamide—Feeling abnormal—Bleomycin—melanoma	0.00168	0.00242	CcSEcCtD
Dorzolamide—Agranulocytosis—Docetaxel—melanoma	0.00167	0.00241	CcSEcCtD
Dorzolamide—Hypotension—Carmustine—melanoma	0.00166	0.0024	CcSEcCtD
Dorzolamide—Hyperhidrosis—Temozolomide—melanoma	0.00166	0.0024	CcSEcCtD
Dorzolamide—Decreased appetite—Dactinomycin—melanoma	0.00165	0.00238	CcSEcCtD
Dorzolamide—Fatigue—Dactinomycin—melanoma	0.00164	0.00236	CcSEcCtD
Dorzolamide—Anorexia—Temozolomide—melanoma	0.00164	0.00236	CcSEcCtD
Dorzolamide—Pain—Dactinomycin—melanoma	0.00162	0.00234	CcSEcCtD
Dorzolamide—Musculoskeletal discomfort—Carmustine—melanoma	0.00162	0.00234	CcSEcCtD
Dorzolamide—Urticaria—Bleomycin—melanoma	0.00162	0.00234	CcSEcCtD
Dorzolamide—Body temperature increased—Bleomycin—melanoma	0.00161	0.00232	CcSEcCtD
Dorzolamide—Insomnia—Carmustine—melanoma	0.00161	0.00232	CcSEcCtD
Dorzolamide—Paraesthesia—Carmustine—melanoma	0.00159	0.0023	CcSEcCtD
Dorzolamide—Pharyngitis—Docetaxel—melanoma	0.00159	0.0023	CcSEcCtD
Dorzolamide—Dyspnoea—Carmustine—melanoma	0.00158	0.00229	CcSEcCtD
Dorzolamide—Somnolence—Carmustine—melanoma	0.00158	0.00228	CcSEcCtD
Dorzolamide—Feeling abnormal—Dactinomycin—melanoma	0.00156	0.00226	CcSEcCtD
Dorzolamide—Musculoskeletal discomfort—Temozolomide—melanoma	0.00156	0.00226	CcSEcCtD
Dorzolamide—Insomnia—Temozolomide—melanoma	0.00155	0.00224	CcSEcCtD
Dorzolamide—Gastrointestinal pain—Dactinomycin—melanoma	0.00155	0.00224	CcSEcCtD
Dorzolamide—Visual impairment—Docetaxel—melanoma	0.00155	0.00224	CcSEcCtD
Dorzolamide—Decreased appetite—Carmustine—melanoma	0.00154	0.00223	CcSEcCtD
Dorzolamide—Paraesthesia—Temozolomide—melanoma	0.00154	0.00223	CcSEcCtD
Dorzolamide—CA5B—lymph node—melanoma	0.00154	0.0181	CbGeAlD
Dorzolamide—Dyspnoea—Temozolomide—melanoma	0.00153	0.00221	CcSEcCtD
Dorzolamide—Somnolence—Temozolomide—melanoma	0.00153	0.0022	CcSEcCtD
Dorzolamide—Erythema multiforme—Docetaxel—melanoma	0.00152	0.00219	CcSEcCtD
Dorzolamide—Pain—Carmustine—melanoma	0.00152	0.00219	CcSEcCtD
Dorzolamide—CA4—head—melanoma	0.00152	0.0178	CbGeAlD
Dorzolamide—Dyspepsia—Temozolomide—melanoma	0.00151	0.00218	CcSEcCtD
Dorzolamide—Body temperature increased—Dactinomycin—melanoma	0.0015	0.00217	CcSEcCtD
Dorzolamide—Abdominal pain—Dactinomycin—melanoma	0.0015	0.00217	CcSEcCtD
Dorzolamide—Hypersensitivity—Bleomycin—melanoma	0.0015	0.00217	CcSEcCtD
Dorzolamide—Decreased appetite—Temozolomide—melanoma	0.00149	0.00216	CcSEcCtD
Dorzolamide—Fatigue—Temozolomide—melanoma	0.00148	0.00214	CcSEcCtD
Dorzolamide—Pain—Temozolomide—melanoma	0.00147	0.00212	CcSEcCtD
Dorzolamide—Feeling abnormal—Carmustine—melanoma	0.00146	0.00211	CcSEcCtD
Dorzolamide—Asthenia—Bleomycin—melanoma	0.00146	0.00211	CcSEcCtD
Dorzolamide—Gastrointestinal pain—Carmustine—melanoma	0.00145	0.0021	CcSEcCtD
Dorzolamide—Pruritus—Bleomycin—melanoma	0.00144	0.00208	CcSEcCtD
Dorzolamide—Arrhythmia—Docetaxel—melanoma	0.00143	0.00207	CcSEcCtD
Dorzolamide—Alopecia—Docetaxel—melanoma	0.00142	0.00205	CcSEcCtD
Dorzolamide—Feeling abnormal—Temozolomide—melanoma	0.00141	0.00204	CcSEcCtD
Dorzolamide—Abdominal pain—Carmustine—melanoma	0.0014	0.00203	CcSEcCtD
Dorzolamide—Body temperature increased—Carmustine—melanoma	0.0014	0.00203	CcSEcCtD
Dorzolamide—Gastrointestinal pain—Temozolomide—melanoma	0.0014	0.00203	CcSEcCtD
Dorzolamide—Erythema—Docetaxel—melanoma	0.0014	0.00202	CcSEcCtD
Dorzolamide—Hypersensitivity—Dactinomycin—melanoma	0.0014	0.00202	CcSEcCtD
Dorzolamide—Dysgeusia—Docetaxel—melanoma	0.00137	0.00198	CcSEcCtD
Dorzolamide—Urticaria—Temozolomide—melanoma	0.00136	0.00197	CcSEcCtD
Dorzolamide—Asthenia—Dactinomycin—melanoma	0.00136	0.00197	CcSEcCtD
Dorzolamide—CA1—lymph node—melanoma	0.00136	0.016	CbGeAlD
Dorzolamide—Abdominal pain—Temozolomide—melanoma	0.00136	0.00196	CcSEcCtD
Dorzolamide—Body temperature increased—Temozolomide—melanoma	0.00136	0.00196	CcSEcCtD
Dorzolamide—Back pain—Docetaxel—melanoma	0.00135	0.00195	CcSEcCtD
Dorzolamide—Hypersensitivity—Carmustine—melanoma	0.00131	0.00189	CcSEcCtD
Dorzolamide—Diarrhoea—Dactinomycin—melanoma	0.0013	0.00188	CcSEcCtD
Dorzolamide—Vomiting—Bleomycin—melanoma	0.00129	0.00187	CcSEcCtD
Dorzolamide—Rash—Bleomycin—melanoma	0.00128	0.00185	CcSEcCtD
Dorzolamide—Dermatitis—Bleomycin—melanoma	0.00128	0.00185	CcSEcCtD
Dorzolamide—Asthenia—Carmustine—melanoma	0.00127	0.00184	CcSEcCtD
Dorzolamide—Hypersensitivity—Temozolomide—melanoma	0.00126	0.00183	CcSEcCtD
Dorzolamide—CA2—head—melanoma	0.00126	0.0148	CbGeAlD
Dorzolamide—Syncope—Docetaxel—melanoma	0.00125	0.00181	CcSEcCtD
Dorzolamide—Palpitations—Docetaxel—melanoma	0.00124	0.00179	CcSEcCtD
Dorzolamide—Asthenia—Temozolomide—melanoma	0.00123	0.00178	CcSEcCtD
Dorzolamide—Loss of consciousness—Docetaxel—melanoma	0.00123	0.00178	CcSEcCtD
Dorzolamide—Cough—Docetaxel—melanoma	0.00122	0.00176	CcSEcCtD
Dorzolamide—Diarrhoea—Carmustine—melanoma	0.00121	0.00176	CcSEcCtD
Dorzolamide—Pruritus—Temozolomide—melanoma	0.00121	0.00175	CcSEcCtD
Dorzolamide—Nausea—Bleomycin—melanoma	0.00121	0.00175	CcSEcCtD
Dorzolamide—Hypertension—Docetaxel—melanoma	0.00121	0.00174	CcSEcCtD
Dorzolamide—Vomiting—Dactinomycin—melanoma	0.00121	0.00174	CcSEcCtD
Dorzolamide—Rash—Dactinomycin—melanoma	0.0012	0.00173	CcSEcCtD
Dorzolamide—Arthralgia—Docetaxel—melanoma	0.00119	0.00172	CcSEcCtD
Dorzolamide—Chest pain—Docetaxel—melanoma	0.00119	0.00172	CcSEcCtD
Dorzolamide—Dizziness—Carmustine—melanoma	0.00117	0.0017	CcSEcCtD
Dorzolamide—Diarrhoea—Temozolomide—melanoma	0.00117	0.0017	CcSEcCtD
Dorzolamide—Dry mouth—Docetaxel—melanoma	0.00116	0.00168	CcSEcCtD
Dorzolamide—Confusional state—Docetaxel—melanoma	0.00115	0.00166	CcSEcCtD
Dorzolamide—Oedema—Docetaxel—melanoma	0.00114	0.00165	CcSEcCtD
Dorzolamide—Anaphylactic shock—Docetaxel—melanoma	0.00114	0.00165	CcSEcCtD
Dorzolamide—Dizziness—Temozolomide—melanoma	0.00113	0.00164	CcSEcCtD
Dorzolamide—Vomiting—Carmustine—melanoma	0.00113	0.00163	CcSEcCtD
Dorzolamide—Nausea—Dactinomycin—melanoma	0.00113	0.00163	CcSEcCtD
Dorzolamide—Shock—Docetaxel—melanoma	0.00112	0.00162	CcSEcCtD
Dorzolamide—Rash—Carmustine—melanoma	0.00112	0.00162	CcSEcCtD
Dorzolamide—Dermatitis—Carmustine—melanoma	0.00112	0.00162	CcSEcCtD
Dorzolamide—Headache—Carmustine—melanoma	0.00111	0.00161	CcSEcCtD
Dorzolamide—Vomiting—Temozolomide—melanoma	0.00109	0.00158	CcSEcCtD
Dorzolamide—Anorexia—Docetaxel—melanoma	0.00109	0.00157	CcSEcCtD
Dorzolamide—Rash—Temozolomide—melanoma	0.00108	0.00156	CcSEcCtD
Dorzolamide—Dermatitis—Temozolomide—melanoma	0.00108	0.00156	CcSEcCtD
Dorzolamide—Headache—Temozolomide—melanoma	0.00107	0.00155	CcSEcCtD
Dorzolamide—Hypotension—Docetaxel—melanoma	0.00107	0.00154	CcSEcCtD
Dorzolamide—CA4—lymph node—melanoma	0.00106	0.0125	CbGeAlD
Dorzolamide—Nausea—Carmustine—melanoma	0.00105	0.00152	CcSEcCtD
Dorzolamide—Musculoskeletal discomfort—Docetaxel—melanoma	0.00104	0.0015	CcSEcCtD
Dorzolamide—Insomnia—Docetaxel—melanoma	0.00103	0.00149	CcSEcCtD
Dorzolamide—Paraesthesia—Docetaxel—melanoma	0.00102	0.00148	CcSEcCtD
Dorzolamide—Nausea—Temozolomide—melanoma	0.00102	0.00147	CcSEcCtD
Dorzolamide—Dyspnoea—Docetaxel—melanoma	0.00102	0.00147	CcSEcCtD
Dorzolamide—Somnolence—Docetaxel—melanoma	0.00101	0.00147	CcSEcCtD
Dorzolamide—Dyspepsia—Docetaxel—melanoma	0.001	0.00145	CcSEcCtD
Dorzolamide—Decreased appetite—Docetaxel—melanoma	0.000992	0.00143	CcSEcCtD
Dorzolamide—Fatigue—Docetaxel—melanoma	0.000984	0.00142	CcSEcCtD
Dorzolamide—Pain—Docetaxel—melanoma	0.000976	0.00141	CcSEcCtD
Dorzolamide—Feeling abnormal—Docetaxel—melanoma	0.00094	0.00136	CcSEcCtD
Dorzolamide—Gastrointestinal pain—Docetaxel—melanoma	0.000933	0.00135	CcSEcCtD
Dorzolamide—Abdominal pain—Docetaxel—melanoma	0.000902	0.0013	CcSEcCtD
Dorzolamide—Body temperature increased—Docetaxel—melanoma	0.000902	0.0013	CcSEcCtD
Dorzolamide—CA2—lymph node—melanoma	0.00088	0.0103	CbGeAlD
Dorzolamide—Hypersensitivity—Docetaxel—melanoma	0.000841	0.00121	CcSEcCtD
Dorzolamide—Asthenia—Docetaxel—melanoma	0.000819	0.00118	CcSEcCtD
Dorzolamide—Pruritus—Docetaxel—melanoma	0.000807	0.00117	CcSEcCtD
Dorzolamide—Diarrhoea—Docetaxel—melanoma	0.000781	0.00113	CcSEcCtD
Dorzolamide—Dizziness—Docetaxel—melanoma	0.000755	0.00109	CcSEcCtD
Dorzolamide—Vomiting—Docetaxel—melanoma	0.000725	0.00105	CcSEcCtD
Dorzolamide—Rash—Docetaxel—melanoma	0.000719	0.00104	CcSEcCtD
Dorzolamide—Dermatitis—Docetaxel—melanoma	0.000719	0.00104	CcSEcCtD
Dorzolamide—Headache—Docetaxel—melanoma	0.000715	0.00103	CcSEcCtD
Dorzolamide—Nausea—Docetaxel—melanoma	0.000678	0.000979	CcSEcCtD
Dorzolamide—CA12—Metabolism—CYP1B1—melanoma	0.000189	0.000847	CbGpPWpGaD
Dorzolamide—CA14—Metabolism—ABCB1—melanoma	0.000184	0.000827	CbGpPWpGaD
Dorzolamide—CYP2C9—Biological oxidations—CYP1B1—melanoma	0.000182	0.000815	CbGpPWpGaD
Dorzolamide—CA5A—Metabolism—ABCB1—melanoma	0.00018	0.000806	CbGpPWpGaD
Dorzolamide—CA6—Metabolism—ABCB1—melanoma	0.00018	0.000806	CbGpPWpGaD
Dorzolamide—CA9—Cellular responses to stress—VEGFA—melanoma	0.000179	0.000804	CbGpPWpGaD
Dorzolamide—CYP2C9—Metapathway biotransformation—CYP1B1—melanoma	0.000179	0.000803	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—CYP17A1—melanoma	0.000179	0.000802	CbGpPWpGaD
Dorzolamide—CA9—Cellular responses to stress—STAT3—melanoma	0.000178	0.000796	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—CYP17A1—melanoma	0.000171	0.000769	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—VCAN—melanoma	0.000171	0.000768	CbGpPWpGaD
Dorzolamide—CA14—Metabolism—PRKCA—melanoma	0.00017	0.000761	CbGpPWpGaD
Dorzolamide—CA9—Cellular responses to stress—MAPK3—melanoma	0.00017	0.000761	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—GNA11—melanoma	0.000169	0.000758	CbGpPWpGaD
Dorzolamide—CA14—Metabolism—ERCC2—melanoma	0.000168	0.000755	CbGpPWpGaD
Dorzolamide—CA7—Metabolism—ABCB1—melanoma	0.000168	0.000753	CbGpPWpGaD
Dorzolamide—CA5B—Metabolism—ABCB1—melanoma	0.000168	0.000753	CbGpPWpGaD
Dorzolamide—CA5A—Metabolism—PRKCA—melanoma	0.000165	0.000742	CbGpPWpGaD
Dorzolamide—CA6—Metabolism—PRKCA—melanoma	0.000165	0.000742	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—FASN—melanoma	0.000165	0.000742	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—PIP4K2A—melanoma	0.000165	0.000739	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—CYP17A1—melanoma	0.000164	0.000738	CbGpPWpGaD
Dorzolamide—CA6—Metabolism—ERCC2—melanoma	0.000164	0.000736	CbGpPWpGaD
Dorzolamide—CA5A—Metabolism—ERCC2—melanoma	0.000164	0.000736	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—SLC5A5—melanoma	0.000163	0.000729	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—GNA11—melanoma	0.000162	0.000726	CbGpPWpGaD
Dorzolamide—CA9—Cellular responses to stress—MAPK1—melanoma	0.000161	0.000724	CbGpPWpGaD
Dorzolamide—CYP3A4—Tryptophan metabolism—MDM2—melanoma	0.000161	0.000721	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—FASN—melanoma	0.000158	0.000711	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—GNAQ—melanoma	0.000157	0.000704	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—CD44—melanoma	0.000157	0.000704	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—SLC5A5—melanoma	0.000156	0.000699	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—ABCB1—melanoma	0.000155	0.000697	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—GNA11—melanoma	0.000155	0.000696	CbGpPWpGaD
Dorzolamide—CA5B—Metabolism—PRKCA—melanoma	0.000154	0.000693	CbGpPWpGaD
Dorzolamide—CA7—Metabolism—PRKCA—melanoma	0.000154	0.000693	CbGpPWpGaD
Dorzolamide—CA7—Metabolism—ERCC2—melanoma	0.000153	0.000687	CbGpPWpGaD
Dorzolamide—CA5B—Metabolism—ERCC2—melanoma	0.000153	0.000687	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—FASN—melanoma	0.000152	0.000682	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—CYP1B1—melanoma	0.000151	0.000675	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—GNAQ—melanoma	0.000151	0.000675	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—CD44—melanoma	0.000151	0.000675	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—SLC5A5—melanoma	0.000149	0.00067	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—CYP17A1—melanoma	0.000145	0.000648	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—GNAQ—melanoma	0.000144	0.000647	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—CD44—melanoma	0.000144	0.000647	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—CYP1B1—melanoma	0.000144	0.000647	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—PRKCA—melanoma	0.000143	0.000642	CbGpPWpGaD
Dorzolamide—CYP3A4—Biological oxidations—CYP17A1—melanoma	0.000142	0.000638	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—ERCC2—melanoma	0.000142	0.000637	CbGpPWpGaD
Dorzolamide—CYP3A4—Metapathway biotransformation—CYP17A1—melanoma	0.00014	0.000629	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—CYP1B1—melanoma	0.000138	0.000621	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—CUBN—melanoma	0.000137	0.000617	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—GNA11—melanoma	0.000136	0.000612	CbGpPWpGaD
Dorzolamide—CA9—Cellular responses to stress—TP53—melanoma	0.000135	0.000608	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—FASN—melanoma	0.000134	0.000599	CbGpPWpGaD
Dorzolamide—CA14—Metabolism—PIK3CG—melanoma	0.000133	0.000596	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—SLC5A5—melanoma	0.000131	0.000589	CbGpPWpGaD
Dorzolamide—CA6—Metabolism—PIK3CG—melanoma	0.00013	0.000581	CbGpPWpGaD
Dorzolamide—CA5A—Metabolism—PIK3CG—melanoma	0.00013	0.000581	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—GPAM—melanoma	0.000129	0.000577	CbGpPWpGaD
Dorzolamide—CA14—Metabolism—PPARG—melanoma	0.000128	0.000576	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—GNAQ—melanoma	0.000127	0.000569	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—CD44—melanoma	0.000127	0.000569	CbGpPWpGaD
Dorzolamide—CA5A—Metabolism—PPARG—melanoma	0.000125	0.000561	CbGpPWpGaD
Dorzolamide—CA6—Metabolism—PPARG—melanoma	0.000125	0.000561	CbGpPWpGaD
Dorzolamide—CA9—Cellular responses to stress—IL6—melanoma	0.000124	0.000556	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—ABCB1—melanoma	0.000124	0.000556	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—CYP1B1—melanoma	0.000122	0.000546	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—ACER3—melanoma	0.000121	0.000543	CbGpPWpGaD
Dorzolamide—CA5B—Metabolism—PIK3CG—melanoma	0.000121	0.000543	CbGpPWpGaD
Dorzolamide—CA7—Metabolism—PIK3CG—melanoma	0.000121	0.000543	CbGpPWpGaD
Dorzolamide—CYP3A4—Biological oxidations—CYP1B1—melanoma	0.00012	0.000537	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—ABCB1—melanoma	0.000119	0.000533	CbGpPWpGaD
Dorzolamide—CYP3A4—Metapathway biotransformation—CYP1B1—melanoma	0.000118	0.00053	CbGpPWpGaD
Dorzolamide—CA14—Metabolism—PIK3CD—melanoma	0.000117	0.000524	CbGpPWpGaD
Dorzolamide—CA7—Metabolism—PPARG—melanoma	0.000117	0.000524	CbGpPWpGaD
Dorzolamide—CA5B—Metabolism—PPARG—melanoma	0.000117	0.000524	CbGpPWpGaD
Dorzolamide—CA14—Metabolism—ALB—melanoma	0.000115	0.000518	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—PRKCA—melanoma	0.000114	0.000512	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—ABCB1—melanoma	0.000114	0.000511	CbGpPWpGaD
Dorzolamide—CA5A—Metabolism—PIK3CD—melanoma	0.000114	0.000511	CbGpPWpGaD
Dorzolamide—CA6—Metabolism—PIK3CD—melanoma	0.000114	0.000511	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—ERCC2—melanoma	0.000113	0.000508	CbGpPWpGaD
Dorzolamide—CA6—Metabolism—ALB—melanoma	0.000112	0.000504	CbGpPWpGaD
Dorzolamide—CA5A—Metabolism—ALB—melanoma	0.000112	0.000504	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—PIK3CG—melanoma	0.000112	0.000503	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—UGT2B10—melanoma	0.000111	0.000497	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—PRKCA—melanoma	0.000109	0.000491	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G6—melanoma	0.000109	0.00049	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—ERCC2—melanoma	0.000108	0.000487	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—PPARG—melanoma	0.000108	0.000485	CbGpPWpGaD
Dorzolamide—CA5B—Metabolism—PIK3CD—melanoma	0.000106	0.000477	CbGpPWpGaD
Dorzolamide—CA7—Metabolism—PIK3CD—melanoma	0.000106	0.000477	CbGpPWpGaD
Dorzolamide—CA5B—Metabolism—ALB—melanoma	0.000105	0.000471	CbGpPWpGaD
Dorzolamide—CA7—Metabolism—ALB—melanoma	0.000105	0.000471	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—PRKCA—melanoma	0.000105	0.00047	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—ERCC2—melanoma	0.000104	0.000467	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—HS3ST5—melanoma	0.000103	0.000462	CbGpPWpGaD
Dorzolamide—CA14—Metabolism—PIK3CB—melanoma	0.000102	0.000457	CbGpPWpGaD
Dorzolamide—CA14—Metabolism—PTGS2—melanoma	0.000101	0.000453	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—ABCB1—melanoma	0.0001	0.000449	CbGpPWpGaD
Dorzolamide—CA6—Metabolism—PIK3CB—melanoma	9.93e-05	0.000445	CbGpPWpGaD
Dorzolamide—CA5A—Metabolism—PIK3CB—melanoma	9.93e-05	0.000445	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—PIK3CD—melanoma	9.85e-05	0.000442	CbGpPWpGaD
Dorzolamide—CA6—Metabolism—PTGS2—melanoma	9.84e-05	0.000441	CbGpPWpGaD
Dorzolamide—CA5A—Metabolism—PTGS2—melanoma	9.84e-05	0.000441	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—ALB—melanoma	9.73e-05	0.000436	CbGpPWpGaD
Dorzolamide—CA5B—Metabolism—PIK3CB—melanoma	9.27e-05	0.000416	CbGpPWpGaD
Dorzolamide—CA7—Metabolism—PIK3CB—melanoma	9.27e-05	0.000416	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—PRKCA—melanoma	9.22e-05	0.000414	CbGpPWpGaD
Dorzolamide—CA5B—Metabolism—PTGS2—melanoma	9.18e-05	0.000412	CbGpPWpGaD
Dorzolamide—CA7—Metabolism—PTGS2—melanoma	9.18e-05	0.000412	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—ERCC2—melanoma	9.14e-05	0.00041	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—PIK3CG—melanoma	8.94e-05	0.000401	CbGpPWpGaD
Dorzolamide—CA14—Metabolism—PTEN—melanoma	8.8e-05	0.000395	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—PPARG—melanoma	8.63e-05	0.000387	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—PIK3CB—melanoma	8.59e-05	0.000385	CbGpPWpGaD
Dorzolamide—CA5A—Metabolism—PTEN—melanoma	8.58e-05	0.000385	CbGpPWpGaD
Dorzolamide—CA6—Metabolism—PTEN—melanoma	8.58e-05	0.000385	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—PIK3CG—melanoma	8.57e-05	0.000384	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—PTGS2—melanoma	8.51e-05	0.000382	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—CYP17A1—melanoma	8.28e-05	0.000372	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—PPARG—melanoma	8.27e-05	0.000371	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—PIK3CG—melanoma	8.22e-05	0.000368	CbGpPWpGaD
Dorzolamide—CA7—Metabolism—PTEN—melanoma	8.01e-05	0.000359	CbGpPWpGaD
Dorzolamide—CA5B—Metabolism—PTEN—melanoma	8.01e-05	0.000359	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—ACER3—melanoma	7.98e-05	0.000358	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—PPARG—melanoma	7.93e-05	0.000356	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—PIK3CD—melanoma	7.86e-05	0.000352	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—PLCB4—melanoma	7.8e-05	0.00035	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—ALB—melanoma	7.76e-05	0.000348	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—FASN—melanoma	7.66e-05	0.000343	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—PIK3CD—melanoma	7.53e-05	0.000338	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—ALB—melanoma	7.44e-05	0.000334	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—PTEN—melanoma	7.42e-05	0.000333	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—SLC6A11—melanoma	7.33e-05	0.000329	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—PIP4K2A—melanoma	7.33e-05	0.000329	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—UGT2B10—melanoma	7.3e-05	0.000328	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—PIK3CG—melanoma	7.22e-05	0.000324	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—PIK3CD—melanoma	7.22e-05	0.000324	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—MTAP—melanoma	7.13e-05	0.00032	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—ALB—melanoma	7.13e-05	0.00032	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	6.97e-05	0.000313	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—PPARG—melanoma	6.97e-05	0.000313	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—PIK3CB—melanoma	6.85e-05	0.000307	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—HS3ST5—melanoma	6.79e-05	0.000305	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—PTGS2—melanoma	6.79e-05	0.000304	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—PIK3CB—melanoma	6.57e-05	0.000295	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—PTGS2—melanoma	6.51e-05	0.000292	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—PHGDH—melanoma	6.36e-05	0.000285	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—LUM—melanoma	6.36e-05	0.000285	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—PIK3CD—melanoma	6.35e-05	0.000285	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—PIK3CB—melanoma	6.29e-05	0.000282	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—ALB—melanoma	6.27e-05	0.000281	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—PTGS2—melanoma	6.24e-05	0.00028	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—HPSE—melanoma	6.24e-05	0.00028	CbGpPWpGaD
Dorzolamide—CA14—Metabolism—PIK3CA—melanoma	6.21e-05	0.000279	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—CUBN—melanoma	6.12e-05	0.000275	CbGpPWpGaD
Dorzolamide—CA6—Metabolism—PIK3CA—melanoma	6.05e-05	0.000272	CbGpPWpGaD
Dorzolamide—CA5A—Metabolism—PIK3CA—melanoma	6.05e-05	0.000272	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—PTEN—melanoma	5.92e-05	0.000265	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—CSPG4—melanoma	5.91e-05	0.000265	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—SDHD—melanoma	5.91e-05	0.000265	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—BSG—melanoma	5.91e-05	0.000265	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—GPAM—melanoma	5.73e-05	0.000257	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—PTEN—melanoma	5.67e-05	0.000254	CbGpPWpGaD
Dorzolamide—CA5B—Metabolism—PIK3CA—melanoma	5.65e-05	0.000253	CbGpPWpGaD
Dorzolamide—CA7—Metabolism—PIK3CA—melanoma	5.65e-05	0.000253	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—PIK3CB—melanoma	5.53e-05	0.000248	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—PTGS2—melanoma	5.48e-05	0.000246	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—PTEN—melanoma	5.44e-05	0.000244	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—PIK3CA—melanoma	5.24e-05	0.000235	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—PLCB4—melanoma	5.14e-05	0.000231	CbGpPWpGaD
Dorzolamide—CA14—Metabolism—AKT1—melanoma	5.07e-05	0.000228	CbGpPWpGaD
Dorzolamide—CA5A—Metabolism—AKT1—melanoma	4.94e-05	0.000222	CbGpPWpGaD
Dorzolamide—CA6—Metabolism—AKT1—melanoma	4.94e-05	0.000222	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—PLA2G6—melanoma	4.87e-05	0.000218	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—SLC6A11—melanoma	4.84e-05	0.000217	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—PIP4K2A—melanoma	4.84e-05	0.000217	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—PTEN—melanoma	4.78e-05	0.000214	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—MTAP—melanoma	4.71e-05	0.000211	CbGpPWpGaD
Dorzolamide—CA7—Metabolism—AKT1—melanoma	4.62e-05	0.000207	CbGpPWpGaD
Dorzolamide—CA5B—Metabolism—AKT1—melanoma	4.62e-05	0.000207	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—VCAN—melanoma	4.37e-05	0.000196	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—AKT1—melanoma	4.28e-05	0.000192	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—PHGDH—melanoma	4.19e-05	0.000188	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—LUM—melanoma	4.19e-05	0.000188	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—PIK3CA—melanoma	4.17e-05	0.000187	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	4.14e-05	0.000186	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—HPSE—melanoma	4.11e-05	0.000184	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—CUBN—melanoma	4.04e-05	0.000181	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—PIK3CA—melanoma	4e-05	0.00018	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—melanoma	4e-05	0.000179	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—SDHD—melanoma	3.9e-05	0.000175	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—CSPG4—melanoma	3.9e-05	0.000175	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—BSG—melanoma	3.9e-05	0.000175	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—PIK3CA—melanoma	3.84e-05	0.000172	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—GPAM—melanoma	3.78e-05	0.000169	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—CYP17A1—melanoma	3.69e-05	0.000165	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	3.64e-05	0.000163	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—ALB—melanoma	3.59e-05	0.000161	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—GNA11—melanoma	3.48e-05	0.000156	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—AKT1—melanoma	3.41e-05	0.000153	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—FASN—melanoma	3.41e-05	0.000153	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—PIK3CA—melanoma	3.37e-05	0.000151	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—SLC5A5—melanoma	3.35e-05	0.00015	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—AKT1—melanoma	3.27e-05	0.000147	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—GNAQ—melanoma	3.24e-05	0.000145	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—CD44—melanoma	3.24e-05	0.000145	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—PLA2G6—melanoma	3.21e-05	0.000144	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	3.17e-05	0.000142	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—melanoma	3.14e-05	0.000141	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—AKT1—melanoma	3.13e-05	0.000141	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—CYP1B1—melanoma	3.11e-05	0.000139	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—VCAN—melanoma	2.88e-05	0.000129	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—AKT1—melanoma	2.76e-05	0.000124	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—melanoma	2.74e-05	0.000123	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—ABCB1—melanoma	2.56e-05	0.000115	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—CYP17A1—melanoma	2.43e-05	0.000109	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—PRKCA—melanoma	2.35e-05	0.000106	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—ERCC2—melanoma	2.33e-05	0.000105	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—GNA11—melanoma	2.3e-05	0.000103	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—FASN—melanoma	2.25e-05	0.000101	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—SLC5A5—melanoma	2.21e-05	9.92e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—GNAQ—melanoma	2.14e-05	9.58e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—CD44—melanoma	2.14e-05	9.58e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—CYP1B1—melanoma	2.05e-05	9.19e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.93e-05	8.67e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—PIK3CG—melanoma	1.84e-05	8.27e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—PPARG—melanoma	1.78e-05	7.98e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—ABCB1—melanoma	1.69e-05	7.57e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—PIK3CD—melanoma	1.62e-05	7.27e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—ALB—melanoma	1.6e-05	7.18e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—PRKCA—melanoma	1.55e-05	6.96e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—ERCC2—melanoma	1.54e-05	6.91e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—PIK3CB—melanoma	1.41e-05	6.34e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—PTGS2—melanoma	1.4e-05	6.28e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—PTEN—melanoma	1.22e-05	5.48e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—PIK3CG—melanoma	1.22e-05	5.45e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—PPARG—melanoma	1.17e-05	5.26e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—PIK3CD—melanoma	1.07e-05	4.79e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—ALB—melanoma	1.06e-05	4.73e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—PIK3CB—melanoma	9.32e-06	4.18e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—PTGS2—melanoma	9.23e-06	4.14e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—PIK3CA—melanoma	8.61e-06	3.86e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—PTEN—melanoma	8.05e-06	3.61e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—AKT1—melanoma	7.03e-06	3.16e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—PIK3CA—melanoma	5.68e-06	2.55e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—AKT1—melanoma	4.64e-06	2.08e-05	CbGpPWpGaD
